Investigating novel KRAS inhibitors effects on the tumor-immune responses and integration of KRAS inhibition with immune based therapies.
Grant
Overview
date/time interval
-
October 1, 2023 - September 30, 2024
awarded by
administered by
Affiliation
contributor